Contact

All Stories

  1. Proteomic signatures reflect effects of semaglutide treatment for MASH

    Article • JHEP Reports, October 2025, Elsevier

    Clinical Chair Professor Henning Gronbaek

  2. Association rule mining of clinical and biomarker data in neuroendocrine tumors: A prospective study on disease progression

    Article • Journal of Neuroendocrinology, August 2025, Wiley

    Clinical Chair Professor Henning Gronbaek

  3. Anti‐Ro52/TRIM21 autoantibodies predict Sjögren's syndrome in patients with primary biliary cholangitis

    Article • Hepatology Research, May 2025, Wiley

    Clinical Chair Professor Henning Gronbaek

  4. Elevated Liver Enzymes in Turner Syndrome: The Role of Low-grade Inflammation and Hormonal Imbalances

    Article • Journal of the Endocrine Society, April 2025, Endocrine Society

    Clinical Chair Professor Henning Gronbaek

  5. Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer Panels

    Article • Biomolecules, February 2025, MDPI AG

    Clinical Chair Professor Henning Gronbaek

  6. Comparable glucagon-stimulated amino acid suppression in individuals with and without hepatic steatosis or steatohepatitis

    Article • AJP Endocrinology and Metabolism, December 2024, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

  7. A potential novel stratification model to predict cardiovascular disease in patients with metabolic dysfunction-associated steatotic liver disease

    Article • European Journal of Internal Medicine, November 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek

  8. CTX‐III in hepatitis C

    Article • Liver International, August 2024, Wiley

    Clinical Chair Professor Henning Gronbaek

  9. Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites

    Article • Hepatology Communications, June 2024, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  10. Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature

    Article • Journal of Hepatology, May 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek, Professor Amedeo LONARDO

  11. Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease

    Article • European Journal of Internal Medicine, April 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek

  12. Effects of Peptide Receptor Radiotherapy in Patients with Advanced Paraganglioma and Pheochromocytoma: A Nation-Wide Cohort Study

    Article • Cancers, March 2024, MDPI AG

    Clinical Chair Professor Henning Gronbaek

  13. The prevalence and disease course of autoimmune liver diseases in Greenland

    Article • International Journal of Circumpolar Health, March 2024, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  14. Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial

    Article • Hepatology Communications, December 2023, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  15. A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours

    Article • European Journal of Pediatrics, September 2023, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  16. The role of N‐terminal pro‐brain natriuretic peptide, chromogranin A, and 5‐hydroxyindoleacetic acid in screening for carcinoid heart disease

    Article • Journal of Neuroendocrinology, August 2023, Wiley

    Clinical Chair Professor Henning Gronbaek

  17. Fungal translocation measured by serum 1,3‐ß‐D‐glucan correlates with severity and outcome of liver cirrhosis—A pilot study

    Article • Liver International, June 2023, Wiley

    Clinical Chair Professor Henning Gronbaek

  18. Editorial: non‐invasive diagnosis of alcohol‐related steatohepatitis in patients ongoing alcohol withdrawal based on cytokeratin 18 and transient elastography

    Article • Alimentary Pharmacology & Therapeutics, June 2023, Wiley

    Clinical Chair Professor Henning Gronbaek

  19. A nationwide study of autoimmune liver diseases in the Faroe Islands: Incidence, prevalence, and causes of death 2004 - 2021

    Article • International Journal of Circumpolar Health, June 2023, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  20. Soluble CD163 as a biomarker of liver fibrosis in liver transplant recipients

    Article • Journal of Hepatology, June 2023, Elsevier

    Clinical Chair Professor Henning Gronbaek

  21. Alcohol‐related liver disease phenotype impacts survival after an acute variceal bleeding episode

    Article • Liver International, May 2023, Wiley

    Clinical Chair Professor Henning Gronbaek

  22. Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms

    Article • Acta Oncologica, May 2023, Acta Dermato-Venereologica

    Clinical Chair Professor Henning Gronbaek

  23. Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease

    Article • Atherosclerosis, May 2023, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Mogens Johannsen

  24. The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis

    Article • Hepatology Communications, March 2023, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  25. The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation

    Article • British Journal of Pharmacology, January 2023, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  26. The Prevalence of Inflammatory Bowel Disease in Greenland

    Article • Inflammatory Bowel Diseases, January 2023, Oxford University Press (OUP)

    Clinical Chair Professor Henning Gronbaek

  27. Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease

    Article • European Journal of Pediatrics, December 2022, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  28. Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumours

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, September 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  29. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Article • Gut, September 2022, BMJ

    Clinical Chair Professor Henning Gronbaek

  30. Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)

    Article • Diabetes, August 2022, American Diabetes Association

    Clinical Chair Professor Henning Gronbaek

  31. Development and validation of the Cirrhotic Ascites Severity model—A patient‐reported outcome‐based model to predict 1‐year mortality

    Article • Hepatology Communications, August 2022, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  32. Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease

    Article • Expert Opinion on Therapeutic Targets, August 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  33. von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance

    Article • European Journal of Medical Genetics, August 2022, Elsevier

    Clinical Chair Professor Henning Gronbaek

  34. Fatigue and quality of life in patients with neuroendocrine neoplasia

    Article • Scandinavian Journal of Gastroenterology, July 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  35. Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients

    Article • Frontiers in Endocrinology, June 2022, Frontiers

    Clinical Chair Professor Henning Gronbaek

  36. The presence of interferon affects the progression of non-alcoholic fatty liver disease

    Article • Genes & Immunity, June 2022, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  37. Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumours and differentiation from small intestinal neuroendocrine tumours

    Article • Journal of Neuroendocrinology, June 2022, Wiley

    Clinical Chair Professor Henning Gronbaek

  38. 276-OR: Impaired Glucagon-Mediated Suppression of VLDL-TG Secretion in Individuals with MAFLD

    Article • Diabetes, June 2022, American Diabetes Association

    Clinical Chair Professor Henning Gronbaek

  39. Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis

    Article • World Journal of Hepatology, April 2022, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

  40. Non-alcoholic fatty liver disease in patients with type 2 diabetes in Greenland: a register-based cross-sectional study

    Article • International Journal of Circumpolar Health, April 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  41. Clinical Progression of Metabolic-Associated Fatty Liver Disease Is Rare in a Danish Tertiary Liver Center

    Article • Journal of Clinical Medicine, April 2022, MDPI AG

    Clinical Chair Professor Henning Gronbaek

  42. Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases

    Article • Journal of Clinical and Translational Hepatology, March 2022, Xia & He Publishing

    Clinical Chair Professor Henning Gronbaek

  43. The NAFLD‐MAFLD debate: Is there a Consensus‐on‐Consensus methodology?

    Article • Liver International, February 2022, Wiley

    Clinical Chair Professor Henning Gronbaek

  44. The galactose elimination capacity test to monitor liver disease course in patients with Wilson’s disease

    Article • Scandinavian Journal of Gastroenterology, January 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  45. Contacts to general practice in the 12 months preceding a diagnosis of an abdominal cancer: a national register-based cohort study

    Article • Scandinavian Journal of Primary Health Care, January 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  46. Prognosis of Patients with Bronchopulmonary Neuroendocrine Neoplasms in a Tertiary Neuroendocrine Tumor Centre of Excellence

    Article • Neuroendocrinology, January 2022, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  47. Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass

    Article • Physiological Reports, January 2022, Wiley

    Clinical Chair Professor Henning Gronbaek

  48. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure

    Article • JHEP Reports, December 2021, Elsevier

    Clinical Chair Professor Henning Gronbaek

  49. A novel read methodology to evaluate the optimal dose of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial

    Article • EJNMMI Research, September 2021, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  50. Metformin Stimulates Intestinal Glycolysis and Lactate Release: A single‐Dose Study of Metformin in Patients With Intrahepatic Portosystemic Stent

    Article • Clinical Pharmacology & Therapeutics, August 2021, Wiley

    Clinical Chair Professor Henning Gronbaek

  51. Cognitive impairment in stable Wilson disease across phenotype

    Article • Metabolic Brain Disease, August 2021, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  52. Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis

    Article • Journal of Hepatology, August 2021, Elsevier

    Clinical Chair Professor Henning Gronbaek

  53. Editorial: metformin for portal hypertension—old dog, new tricks? Authors' reply

    Article • Alimentary Pharmacology & Therapeutics, July 2021, Wiley

    Clinical Chair Professor Henning Gronbaek

  54. A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for 68Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors

    Article • Journal of Nuclear Medicine, July 2021, Society of Nuclear Medicine

    Clinical Chair Professor Henning Gronbaek

  55. Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults

    Article • European Journal of Endocrinology, July 2021, Oxford University Press (OUP)

    Clinical Chair Professor Henning Gronbaek

  56. Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertension

    Article • Alimentary Pharmacology & Therapeutics, June 2021, Wiley

    Clinical Chair Professor Henning Gronbaek

  57. Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension

    Article • Frontiers in Physiology, June 2021, Frontiers

    Clinical Chair Professor Henning Gronbaek

  58. Abdominal investigations in the year preceding a diagnosis of abdominal cancer: A register-based cohort study in Denmark

    Article • Cancer Epidemiology, June 2021, Elsevier

    Clinical Chair Professor Henning Gronbaek

  59. Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

    Article • Acta Oncologica, May 2021, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  60. Cognitive Impairment In Stable Wilson Disease Across Phenotype.

    Article • May 2021, Research Square

    Clinical Chair Professor Henning Gronbaek

  61. Core liver homeostatic co-expression networks are preserved but respond to perturbations in an organism- and disease-specific manner

    Article • Cell Systems, May 2021, Elsevier

    Clinical Chair Professor Henning Gronbaek

  62. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Article • Journal of Hepatology, May 2021, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Maurizio Baldassarre

  63. P316 Human neutrophil elastase derived fragment of calprotectin (S100a9) is a serum biomarker (CPa9-HNE) for monitoring of anti-TNFα treatment response in Crohn’s disease

    Article • Journal of Crohn s and Colitis, May 2021, Oxford University Press (OUP)

    Clinical Chair Professor Henning Gronbaek

  64. Cancer suspicion, referral to cancer patient pathway and primary care interval: a survey and register study exploring 10 different types of abdominal cancer

    Article • Family Practice, April 2021, Oxford University Press (OUP)

    Clinical Chair Professor Henning Gronbaek

  65. Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma

    Article • BMC Cancer, April 2021, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  66. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2021, New England Journal of Medicine (NEJM/MMS)

    Clinical Chair Professor Henning Gronbaek

  67. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis

    Article • Clinical and Translational Gastroenterology, March 2021, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  68. Interferon lambda 4 genotype and pathway in alcoholic hepatitis

    Article • Scandinavian Journal of Gastroenterology, February 2021, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  69. Efficacy of Dietary Manipulations for Depleting Intrahepatic Triglyceride Content: Implications for the Management of Non-alcoholic Fatty Liver Disease

    Article • Current Obesity Reports, February 2021, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek, Professor Maria Dalamaga

  70. Increased occurrence of liver and gastrointestinal diseases and anaemia in women with Turner syndrome – a nationwide cohort study

    Article • Alimentary Pharmacology & Therapeutics, February 2021, Wiley

    Clinical Chair Professor Henning Gronbaek

  71. No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation

    Article • Clinical and Translational Gastroenterology, January 2021, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  72. Administrative coding in electronic health care record‐based research of NAFLD: an expert panel consensus statement

    Article • Hepatology, January 2021, Wiley

    Clinical Chair Professor Henning Gronbaek

  73. Clinical efficacy of first and second series of peptide receptor radionuclide therapy in patients with neuroendocrine neoplasm: a cohort study

    Article • Scandinavian Journal of Gastroenterology, January 2021, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  74. CELL-FREE DNA AND CLINICAL CHARACTERISTICS IN PATIENTS WITH SMALL INTESTINAL OR PANCREATIC NEUROENDOCRINE TUMORS

    Article • Neuroendocrinology, January 2021, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  75. Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis

    Article • Frontiers in Medicine, January 2021, Frontiers

    Clinical Chair Professor Henning Gronbaek

  76. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data

    Article • Gastroenterology, January 2021, Elsevier

    Clinical Chair Professor Henning Gronbaek

  77. Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease

    Article • Frontiers in Medicine, December 2020, Frontiers

    Clinical Chair Professor Henning Gronbaek

  78. PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

    Article • PLOS One, December 2020, PLOS

    Clinical Chair Professor Henning Gronbaek

  79. Macrophage markers and innate immunity in cirrhosis

    Article • Journal of Hepatology, December 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  80. Altered balance between collagen formation and degradation after successful direct‐acting antiviral therapy of chronic hepatitis C

    Article • Journal of Viral Hepatitis, November 2020, Wiley

    Clinical Chair Professor Henning Gronbaek

  81. First trimester biomarkers for prediction of gestational diabetes mellitus

    Article • Placenta, November 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  82. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

    Article • Journal of Hepatology, November 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  83. TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma

    Article • Scandinavian Journal of Gastroenterology, October 2020, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  84. Combining Tissue and Circulating Tumor DNA Increases the Detection Rate of CTNNB1 Mutation in Hepatocellular Carcinoma

    Article • October 2020, Research Square

    Clinical Chair Professor Henning Gronbaek

  85. Thrombophilia testing in patients with portal vein thrombosis

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, October 2020, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  86. One Year’s Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

    Article • Journal of Clinical Medicine, October 2020, MDPI AG

    Clinical Chair Professor Henning Gronbaek

  87. A consensus developed morphological re-evaluation of 196 high-grade gastroenteropancreatic neuroendocrine neoplasms and its clinical correlations.

    Article • Neuroendocrinology, October 2020, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  88. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Article • Journal of Hepatology, October 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Maurizio Baldassarre

  89. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?

    Article • Expert Review of Gastroenterology & Hepatology, September 2020, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  90. Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study

    Article • Clinical and Translational Gastroenterology, September 2020, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  91. The effect of acute intragastric vs. intravenous alcohol administration on inflammation markers, blood lipids and gallbladder motility in healthy men

    Article • Alcohol, September 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  92. 1006P PD-L1, tumor mutational burden, and overall survival among patients undergoing surgical treatment for hepatocellular carcinoma prior to systemic therapy

    Article • Annals of Oncology, September 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  93. Letter: improve survival! Place early pre-emptive TIPSS in high-risk variceal bleeders

    Article • Alimentary Pharmacology & Therapeutics, August 2020, Wiley

    Clinical Chair Professor Henning Gronbaek

  94. Early normalization of reduced urea synthesis capacity after direct-acting antiviral therapy in hepatitis C cirrhosis

    Article • AJP Gastrointestinal and Liver Physiology, August 2020, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

  95. Progression of non-alcoholic fatty liver disease is rare in a Danish tertiary liver centre

    Article • Journal of Hepatology, August 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  96. Early-tips should be performed in high-risk cirrhotic patients despite the presence of hepatic encephalopathy at admission

    Article • Journal of Hepatology, August 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  97. Pre-emptive (early) transjugular intrahepatic porto-systemic shunt in the treatment of high-risk acute variceal bleeding. An individual patient data meta-analysis

    Article • Journal of Hepatology, August 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  98. A plasma protein biomarker strategy for detection of small intestinal neuroendocrine tumors

    Article • Neuroendocrinology, July 2020, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  99. Clinical Efficacy of First and Second Series of Peptide Receptor Radionuclide Therapy in Patients With Neuroendocrine Neoplasm: A Cohort Study

    Article • July 2020, Research Square

    Clinical Chair Professor Henning Gronbaek

  100. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis

    Article • BMC Gastroenterology, July 2020, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  101. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease

    Article • Orphanet Journal of Rare Diseases, July 2020, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  102. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

    Article • Journal of Hepatology, July 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  103. Liver-related effects of chronic hepatitis C antiviral treatment

    Article • World Journal of Gastroenterology, June 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

  104. Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy

    Article • Alimentary Pharmacology & Therapeutics, June 2020, Wiley

    Clinical Chair Professor Henning Gronbaek

  105. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute‐on‐chronic liver failure and acute decompensation

    Article • Journal of Gastroenterology and Hepatology, June 2020, Wiley

    Clinical Chair Professor Henning Gronbaek

  106. Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701]

    Article • Journal of Hepatology, June 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Maurizio Baldassarre

  107. The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease

    Article • Trends in Genetics, June 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  108. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease

    Article • Scandinavian Journal of Gastroenterology, May 2020, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  109. Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure

    Article • Cells, May 2020, MDPI AG

    Clinical Chair Professor Henning Gronbaek

  110. Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease

    Article • Autoimmunity, May 2020, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  111. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

    Article • Gastroenterology, May 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek

  112. Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis

    Article • Liver International, April 2020, Wiley

    Clinical Chair Professor Henning Gronbaek

  113. The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFα Treatment in Crohn’s Disease

    Article • Journal of Clinical Gastroenterology, April 2020, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  114. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

    Article • Journal of Hepatology, April 2020, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Maurizio Baldassarre

  115. Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors

    Article • Anti-Cancer Drugs, March 2020, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  116. New tight junction protein 2 variant causing progressive familial intrahepatic cholestasis type 4 in adults: A case report

    Article • World Journal of Gastroenterology, February 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

  117. Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial

    Article • BMJ Open, January 2020, BMJ

    Dr Nina Kimer, Clinical Chair Professor Henning Gronbaek

  118. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    Article • The Lancet, December 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  119. Plasma chromogranin A (CgA) as a predictor of progression in patients with neuroendocrine tumors.

    Article • Neuroendocrinology, October 2019, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  120. Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C

    Article • Journal of Viral Hepatitis, October 2019, Wiley

    Clinical Chair Professor Henning Gronbaek

  121. Use of complimentary medicines in patients with neuroendocrine tumors.

    Article • Scandinavian Journal of Gastroenterology, August 2019, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  122. Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis

    Article • Clinical Gastroenterology and Hepatology, August 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  123. Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial

    Article • EBioMedicine, August 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  124. Insulin resistance, liver inflammation and fibrosis in patients with NAFLD

    Article • Journal of Hepatology, July 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Amalia Gastaldelli

  125. The macrophage‐related biomarkers sCD163 and sCD206 are released by different shedding mechanisms

    Article • Journal of Leukocyte Biology, June 2019, Wiley

    Clinical Chair Professor Henning Gronbaek

  126. 551 OPTIMAL TIMING OF ENDOSCOPY IS ASSOCIATED WITH LOWER 42-DAY MORTALITY IN VARICEAL BLEEDING

    Article • Gastrointestinal Endoscopy, June 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  127. Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study

    Article • Alimentary Pharmacology & Therapeutics, May 2019, Wiley

    Clinical Chair Professor Henning Gronbaek

  128. Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose

    Article • Scandinavian Journal of Gastroenterology, May 2019, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  129. The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation

    Article • Journal of Clinical and Experimental Hepatology, May 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  130. Hepatic exposure of metformin in patients with non‐alcoholic fatty liver disease

    Article • British Journal of Clinical Pharmacology, April 2019, Wiley

    Clinical Chair Professor Henning Gronbaek

  131. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals

    Article • AJP Gastrointestinal and Liver Physiology, April 2019, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

  132. FRI-339-Clinical translatability of a diet-induced obese mouse model of non-alcoholic steatohepatitis

    Article • Journal of Hepatology, April 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  133. PS-023-Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS

    Article • Journal of Hepatology, April 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  134. THU-324-Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions

    Article • Journal of Hepatology, April 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  135. PS-022-Optimal timing of endoscopy is associated with lower 42-day mortality in variceal bleeding

    Article • Journal of Hepatology, April 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  136. THU-325-Regional liver function investigated by galactose positron emission tomography is reduced in patients with non-alcoholic steatohepatitis

    Article • Journal of Hepatology, April 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  137. SAT-079-Respiratory infection in patients with cirrhosis and acute variceal bleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patients

    Article • Journal of Hepatology, April 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  138. FRI-120-Structural liver disease rather than portal hypertension is the predominant factor for hepatic macrophage activation in patients with cirrhosis, portal vein thrombosis and idiopathic portal hypertension

    Article • Journal of Hepatology, April 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  139. FRI-016-Validation of the PREsTo machine learning algorithm for the prediction of disease progression in patients with primary sclerosing cholangitis

    Article • Journal of Hepatology, April 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  140. Effects of implementation of a national fast track clinical pathway for hepatocellular carcinoma in western Denmark

    Article • Journal of Gastrointestinal and Liver Diseases, March 2019, Romanian Society of Gastroenterology and Heptatology

    Clinical Chair Professor Henning Gronbaek

  141. Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects

    Article • World Journal of Hepatology, February 2019, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

  142. Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions

    Article • Clinics and Research in Hepatology and Gastroenterology, February 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  143. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark

    Article • Growth Hormone & IGF Research, February 2019, Elsevier

    Clinical Chair Professor Henning Gronbaek

  144. P282 Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn’s disease

    Article • Journal of Crohn s and Colitis, January 2019, Oxford University Press (OUP)

    Clinical Chair Professor Henning Gronbaek

  145. Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

    Article • BMC Cancer, January 2019, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  146. Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

    Article • Hepatology, December 2018, Wiley

    Dr Joan Genesca, Clinical Chair Professor Henning Gronbaek

  147. Orchestration of Tryptophan-Kynurenine pathway, acute decompensation and acute-on-chronic liver failure in cirrhosis

    Article • Hepatology, December 2018, Wiley

    Clinical Chair Professor Henning Gronbaek

  148. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

    Article • Nature Reviews Gastroenterology & Hepatology, November 2018, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  149. Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease

    Article • Journal of Pediatric Gastroenterology and Nutrition, November 2018, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  150. Urea cycle dysregulation in non-alcoholic fatty liver disease

    Article • Journal of Hepatology, October 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  151. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study

    Article • Orphanet Journal of Rare Diseases, September 2018, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  152. No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial

    Article • PLOS One, September 2018, PLOS

    Clinical Chair Professor Henning Gronbaek

  153. The Risk of Second Primary Colorectal Adenocarcinomas is not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms – A Nationwide Population Based Study

    Article • Neuroendocrinology, August 2018, Karger Publishers

    Clinical Chair Professor Henning Gronbaek, Tine Gregersen

  154. The role of IFN in the development of NAFLD and NASH

    Article • Cytokine, August 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  155. β-Blockers Improve Presinusoidal Portal Hypertension

    Article • Digestive Diseases and Sciences, July 2018, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  156. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology

    Article • Scandinavian Journal of Gastroenterology, July 2018, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  157. No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease

    Article • Diabetes Obesity and Metabolism, July 2018, Wiley

    Clinical Chair Professor Henning Gronbaek

  158. The Effect of Ethanol on Inflammation Markers and FGF-21 in Healthy Individuals

    Article • Diabetes, July 2018, American Diabetes Association

    Clinical Chair Professor Henning Gronbaek

  159. Soluble CD163 correlates with lipid metabolic adaptations in human type 1 diabetes patients during ketoacidosis

    Article • Journal of Diabetes Investigation, May 2018, Wiley

    Clinical Chair Professor Henning Gronbaek

  160. Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients

    Article • Journal of Hepatology, April 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  161. Albumin administration in the prevention of hepatorenal syndrome (HRS) and death in patients with advanced cirrhosis and non-SBP infections

    Article • Journal of Hepatology, April 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  162. Combinations of inflammatory markers, soluble (s)CD163, mannose receptor (sMR) and neutrophil gelatinase associated lipocalin (NGAL), predicts mortality in patients with acute-on-chronic liver failure

    Article • Journal of Hepatology, April 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  163. Epigenetic modification of urea cycle enzymes in NAFLD animal models and patients: Implications for novel therapeutic approaches

    Article • Journal of Hepatology, April 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  164. Loss of colonization resistance in cirrhosis facilitates proton pump inhibitor-associated oralization of the colonic microbiome

    Article • Journal of Hepatology, April 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  165. Prognosis in patients with primary biliary cholangitis based on histological stage at diagnosis. A nationwide population-based study

    Article • Journal of Hepatology, April 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  166. The Galactose Elimination Capacity test may monitor treatment response and disease progression in patients with Wilson Disease

    Article • Journal of Hepatology, April 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  167. The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality

    Article • Journal of Hepatology, April 2018, Elsevier

    Clinical Chair Professor Henning Gronbaek

  168. Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease

    Article • PLOS One, March 2018, PLOS

    Clinical Chair Professor Henning Gronbaek

  169. Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

    Article • Medical Oncology, March 2018, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  170. Adult Presentation of Noncirrhotic Portal Hypertension and Ascites following Treatment for Wilms’ Tumor in Childhood

    Article • Case Reports in Gastroenterology, February 2018, Karger Publishers

    Linda Kievit, Clinical Chair Professor Henning Gronbaek

  171. Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis

    Article • World Journal of Hepatology, January 2018, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

  172. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment

    Article • Journal of Gastroenterology and Hepatology, January 2018, Wiley

    Clinical Chair Professor Henning Gronbaek, Prof Henry LY Chan

  173. Nutritional status and nutritional risk in patients with neuroendocrine tumors

    Article • Scandinavian Journal of Gastroenterology, January 2018, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  174. Cell death markers in patients with cirrhosis and acute decompensation

    Article • Hepatology, January 2018, Wiley

    Clinical Chair Professor Henning Gronbaek

  175. Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination

    Article • Scandinavian Journal of Gastroenterology, January 2018, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  176. Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial

    Article • Endocrine Connections, January 2018, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  177. Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation

    Article • Alimentary Pharmacology & Therapeutics, December 2017, Wiley

    Clinical Chair Professor Henning Gronbaek

  178. The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients

    Article • PLOS One, December 2017, PLOS

    Clinical Chair Professor Henning Gronbaek

  179. Corrigendum

    Article • Alimentary Pharmacology & Therapeutics, December 2017, Wiley

    Clinical Chair Professor Henning Gronbaek

  180. Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study

    Article • Annals of Surgical Oncology, December 2017, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  181. Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

    Article • The Lancet Oncology, December 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  182. Time course of compromised urea synthesis in patients with alcoholic hepatitis

    Article • Scandinavian Journal of Gastroenterology, November 2017, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  183. Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

    Article • PLOS One, November 2017, PLOS

    Clinical Chair Professor Henning Gronbaek

  184. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas

    Article • European Journal of Surgical Oncology, September 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  185. High burden of coronary atherosclerosis in patients with cirrhosis

    Article • European Journal of Clinical Investigation, July 2017, Wiley

    Clinical Chair Professor Henning Gronbaek

  186. Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, July 2017, Taylor & Francis

    Dr Mark W Douglas, Clinical Chair Professor Henning Gronbaek, professor adrian bauman

  187. Letter: autoimmune hepatitis-drug-induced liver injury must always be excluded. Authors’ reply

    Article • Alimentary Pharmacology & Therapeutics, July 2017, Wiley

    Clinical Chair Professor Henning Gronbaek

  188. A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

    Article • Endocrine Related Cancer, June 2017, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  189. Isolated congenital hepatic fibrosis associated with TMEM67 mutations: report of a new genotype-phenotype relationship

    Article • Clinical Case Reports, May 2017, Wiley

    Clinical Chair Professor Henning Gronbaek

  190. Enrichment of Genetic Variants in the Glucocorticoid Receptor Signalling Pathway in Autoimmune Hepatitis with Failure of Standard Treatment

    Article • Basic & Clinical Pharmacology & Toxicology, May 2017, Wiley

    Clinical Chair Professor Henning Gronbaek

  191. Survival and Predictors of Death for Patients with Bronchopulmonary Carcinoid at a Danish Tertiary NET Centre

    Article • In Vivo, April 2017, International Institute of Anticancer Research

    Clinical Chair Professor Henning Gronbaek

  192. Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study

    Article • Liver International, April 2017, Wiley

    Clinical Chair Professor Henning Gronbaek

  193. IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis

    Article • Nature Genetics, April 2017, Nature

    Clinical Chair Professor Henning Gronbaek

  194. Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes

    Article • Molecular Therapy — Methods & Clinical Development, March 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  195. Long-Term Ethanol Exposure Decreases the Endotoxin-Induced Hepatic Acute Phase Response in Rats

    Article • Alcoholism Clinical and Experimental Research, February 2017, Wiley

    Emilie Glavind, Clinical Chair Professor Henning Gronbaek

  196. Time Course of Compromised Urea Synthesis in Patients With Alcoholic Hepatitis

    Article • Journal of Clinical and Experimental Hepatology, February 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  197. Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease

    Article • January 2017, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  198. Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting

    Article • Acta Dermato-Venereologica, January 2017, Acta Dermato-Venereologica

    Clinical Chair Professor Henning Gronbaek

  199. Enrichment of genetic variants in the glucocorticoid receptor signalling pathway in standard treatment failure autoimmune hepatitis

    Article • Journal of Hepatology, January 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  200. Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosis

    Article • Journal of Hepatology, January 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  201. Soluble (s)CD163 a macrophage activation marker is associated with liver disease severity in patients with Wilson’s disease

    Article • Journal of Hepatology, January 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  202. The macrophage activation marker, soluble CD163 is associated with hepatic inflammation and fibrosis in chronic viral hepatitis C and declines during effective direct-acting antiviral therapy

    Article • Journal of Hepatology, January 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  203. The novel macrophage activation marker soluble Mannose Receptor, and soluble CD163, are elevated after acetaminophen intoxication in relation to liver disease severity

    Article • Journal of Hepatology, January 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  204. Time course of compromised urea synthesis in patients with alcoholic hepatitis

    Article • Journal of Hepatology, January 2017, Elsevier

    Clinical Chair Professor Henning Gronbaek

  205. Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls

    Article • International Journal of Obesity, December 2016, Nature

    Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

  206. A descriptive cross-sectional study of pain in patients with neuroendocrine tumors

    Article • Scandinavian Journal of Gastroenterology, November 2016, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  207. Polymorphisms in the IL‐1 gene cluster influence systemic inflammation in patients at risk for acute‐on‐chronic liver failure

    Article • Hepatology, November 2016, Wiley

    Professor Mauro Bernardi, Clinical Chair Professor Henning Gronbaek

  208. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

    Article • Liver International, November 2016, Wiley

    Dr Joan Genesca, Clinical Chair Professor Henning Gronbaek

  209. The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation

    Article • Liver International, October 2016, Wiley

    Clinical Chair Professor Henning Gronbaek

  210. Contrast-enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer

    Article • Cochrane Database of Systematic Reviews, October 2016, Wiley

    Clinical Chair Professor Henning Gronbaek

  211. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury

    Article • Alimentary Pharmacology & Therapeutics, October 2016, Wiley

    Clinical Chair Professor Henning Gronbaek

  212. Role of macrophages and macrophage activation marker sCD163 in patients with autoimmune hepatitis

    Article • Alimentary Pharmacology & Therapeutics, September 2016, Wiley

    Clinical Chair Professor Henning Gronbaek

  213. Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis

    Article • Scandinavian Journal of Gastroenterology, September 2016, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  214. MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

    Article • Nature Communications, September 2016, Nature

    Clinical Chair Professor Henning Gronbaek

  215. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure

    Article • Hepatology, August 2016, Wiley

    Clinical Chair Professor Henning Gronbaek

  216. Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis

    Article • PLOS One, July 2016, PLOS

    Clinical Chair Professor Henning Gronbaek

  217. The damage-associated molecular pattern HMGB1 is elevated in human alcoholic hepatitis, but does not seem to be a primary driver of inflammation

    Article • Apmis, June 2016, Wiley

    Clinical Chair Professor Henning Gronbaek

  218. Editorial: measuring inflammatory and fibrotic components of portal hypertension - a non-invasive hepatic venous pressure gradient? Authors’ reply

    Article • Alimentary Pharmacology & Therapeutics, June 2016, Wiley

    Clinical Chair Professor Henning Gronbaek

  219. Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children

    Article • European Journal of Clinical Nutrition, June 2016, Nature

    Clinical Chair Professor Henning Gronbaek

  220. The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease

    Article • Liver International, May 2016, Wiley

    Clinical Chair Professor Henning Gronbaek

  221. Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea

    Article • Journal of Neurogastroenterology and Motility, April 2016, The Korean Society of Neurogastroenterology and Motility

    Clinical Chair Professor Henning Gronbaek, Tine Gregersen

  222. The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis

    Article • Alimentary Pharmacology & Therapeutics, April 2016, Wiley

    Clinical Chair Professor Henning Gronbaek

  223. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)

    Article • Journal of Hepatology, April 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek

  224. Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2016, Endocrine Society

    Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

  225. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

    Article • Journal of Hepatology, March 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek

  226. Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment

    Article • Journal of Gastroenterology and Hepatology, February 2016, Wiley

    Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

  227. Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, February 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Amalia Gastaldelli

  228. Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease

    Article • Scandinavian Journal of Gastroenterology, January 2016, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

  229. Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

    Article • January 2016, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  230. Anti-CD163-dexamethasone conjugate inhibits the acute phase response to lipopolysaccharide in rats

    Article • World Journal of Hepatology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

  231. Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease

    Article • January 2016, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  232. Adipose Tissue Insulin Resistance is Associated with Macrophage Activation in Non-Diabetic Patients with Non-Alcoholic Fatty Liver Disease

    Article • Journal of Hepatology, January 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Amalia Gastaldelli

  233. Circulating CD36 Correlates with Intrahepatic Lipid Content in Non-Alcoholic Fatty Liver Disease Patients

    Article • Journal of Hepatology, January 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek

  234. Disease-Related Variants in Genes Involved in Bile Formation and Transport Demonstrated in 12 of 22 Patients with “Unexplained Cholestasis” by the Use of a Novel Panel for Genetic Testing

    Article • Journal of Hepatology, January 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek

  235. Liver Regeneration Capacity after Partial Hepatectomy in Rats with Non-Alcoholic Steatohepatitis

    Article • Journal of Hepatology, January 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek

  236. Macrophage Activation Assessed by Soluble CD163 and Soluble Mannose Receptor is Associated with Liver Injury in Patients with Acetaminophen Overdose

    Article • Journal of Hepatology, January 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek

  237. Patients with Liver Cirrhosis Have Similar Prevalence, but Higher Burden of Coronary Artery Disease Compared to Patients Evaluated for Angina Pectoris

    Article • Journal of Hepatology, January 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek

  238. Polymorphismus in the Interleukin (IL)-1 Gene Cluster Influence the Inflammatory Burden in Patients with Decompensated Cirrhosis and Acute-On-Chronic Liver Failure

    Article • Journal of Hepatology, January 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek

  239. Soluble CD163, a Marker of Macrophage Activation, is Increased in Early Allograft Dysfunction after Liver Transplantation

    Article • Journal of Hepatology, January 2016, Elsevier

    Clinical Chair Professor Henning Gronbaek

  240. Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study

    Article • Annals of Surgical Oncology, December 2015, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  241. Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, November 2015, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  242. Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients

    Article • PLOS One, September 2015, PLOS

    Clinical Chair Professor Henning Gronbaek

  243. Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center

    Article • Acta Radiologica, September 2015, SAGE Publications

    Clinical Chair Professor Henning Gronbaek

  244. The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment

    Article • Growth Hormone & IGF Research, August 2015, Elsevier

    Clinical Chair Professor Henning Gronbaek

  245. Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art

    Article • Acta Oncologica, July 2015, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  246. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery

    Article • Journal of Gastroenterology and Hepatology, July 2015, Wiley

    Clinical Chair Professor Henning Gronbaek

  247. Regional Gastrointestinal Transit Times in Patients With Carcinoid Diarrhea: Assessment With the Novel 3D-Transit System

    Article • Journal of Neurogastroenterology and Motility, July 2015, The Korean Society of Neurogastroenterology and Motility

    Clinical Chair Professor Henning Gronbaek, Tine Gregersen

  248. Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis

    Article • Hepatology, May 2015, Wiley

    Clinical Chair Professor Henning Gronbaek

  249. Monitoring Kidney Function in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC: Associations with Risk Factors

    Article • Current Radiopharmaceuticals, May 2015, Bentham Science Publishers

    Clinical Chair Professor Henning Gronbaek

  250. Effect of resveratrol on experimental non-alcoholic steatohepatitis

    Article • Pharmacological Research, May 2015, Elsevier

    Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

  251. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

    Article • Journal of Hepatology, April 2015, Elsevier

    Clinical Chair Professor Henning Gronbaek

  252. Macrophage activation in obese children with non-alcoholic fatty liver diease

    Article • Journal of Hepatology, April 2015, Elsevier

    Clinical Chair Professor Henning Gronbaek

  253. P0974 : Effects of resveratrol on experimental non-alcoholic steatohepatitis

    Article • Journal of Hepatology, April 2015, Elsevier

    Clinical Chair Professor Henning Gronbaek

  254. P1044 : Randomised, placebo-controlled clinical trial: Long-term resveratrol treatment for non-alcoholic fatty liver disease

    Article • Journal of Hepatology, April 2015, Elsevier

    Clinical Chair Professor Henning Gronbaek

  255. P1061 : The macrophage activation marker SCD163 and the apoptosis marker cytokeratin-18 are both predictors of disease severity in patients with non-alcoholic fatty liver disease

    Article • Journal of Hepatology, April 2015, Elsevier

    Clinical Chair Professor Henning Gronbaek

  256. LP21 : The macrophage activation markers soluble CD206 And CD163 predict mortality in patients with liver cirrhosis and acute-on-chronic liver failure (ACLF)

    Article • Journal of Hepatology, April 2015, Elsevier

    Clinical Chair Professor Henning Gronbaek

  257. Goblet Cell Carcinoids: Characteristics of a Danish Cohort of 83 Patients

    Article • PLOS One, February 2015, PLOS

    Professor Andreas Kjaer, Clinical Chair Professor Henning Gronbaek

  258. Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites

    Article • Scandinavian Journal of Gastroenterology, January 2015, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  259. Reply

    Article • Hepatology, January 2015, Wiley

    Clinical Chair Professor Henning Gronbaek

  260. A Comparison of Three Chromogranin A Assays in Patients with Neuroendocrine Tumours

    Article • Journal of Gastrointestinal and Liver Diseases, December 2014, Romanian Society of Gastroenterology and Heptatology

    Clinical Chair Professor Henning Gronbaek

  261. Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti-TNF-αAntibody Treatment in Active Inflammatory Bowel Disease

    Article • Scandinavian Journal of Immunology, November 2014, Wiley

    Clinical Chair Professor Henning Gronbaek

  262. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure

    Article • Journal of Hepatology, November 2014, Elsevier

    Clinical Chair Professor Henning Gronbaek

  263. Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure

    Article • Liver International, September 2014, Wiley

    Clinical Chair Professor Henning Gronbaek

  264. Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study

    Article • The American Journal of Gastroenterology, August 2014, Nature

    Clinical Chair Professor Henning Gronbaek

  265. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

    Article • Acta Oncologica, August 2014, Acta Dermato-Venereologica

    Dr Seppo W. Langer, Clinical Chair Professor Henning Gronbaek

  266. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C

    Article • Hepatology, August 2014, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  267. The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children

    Article • Pediatric Obesity, July 2014, Wiley

    Clinical Chair Professor Henning Gronbaek

  268. Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2014, New England Journal of Medicine (NEJM/MMS)

    Clinical Chair Professor Henning Gronbaek

  269. Vitamin B12and its binding proteins in hepatocellular carcinoma and chronic liver diseases

    Article • Scandinavian Journal of Gastroenterology, June 2014, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  270. Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic function

    Article • AJP Gastrointestinal and Liver Physiology, June 2014, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

  271. Non-alcoholic steatohepatitis weakens the acute phase response to endotoxin in rats

    Article • Liver International, April 2014, Wiley

    Clinical Chair Professor Henning Gronbaek

  272. P320 ALCOHOLIC HEPATITIS DECREASES THE CAPACITY FOR UREA SYNTHESIS

    Article • Journal of Hepatology, April 2014, Elsevier

    Clinical Chair Professor Henning Gronbaek

  273. P1018 MARKERS OF COLLAGEN REMODELING DETECT CLINICALLY SIGNIFICANT FIBROSIS IN CHRONIC HEPATITIS C PATIENTS

    Article • Journal of Hepatology, April 2014, Elsevier

    Clinical Chair Professor Henning Gronbaek

  274. P1007 SOLUBLE CD163, A MACROPHAGE ACTIVATION MARKER, IS INDEPENDENTLY ASSOCIATED WITH FIBROSIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C

    Article • Journal of Hepatology, April 2014, Elsevier

    Clinical Chair Professor Henning Gronbaek

  275. P824 SOLUBLE CD163, A MACROPHAGE ACTIVATION MARKER, IS INDEPENDENTLY ASSOCIATED WITH STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

    Article • Journal of Hepatology, April 2014, Elsevier

    Clinical Chair Professor Henning Gronbaek

  276. Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes

    Article • International Journal of Experimental Pathology, March 2014, Wiley

    Clinical Chair Professor Henning Gronbaek

  277. Prednisolone but Not Infliximab Aggravates the Upregulated Hepatic Nitrogen Elimination in Patients with Active Inflammatory Bowel Disease

    Article • Inflammatory Bowel Diseases, January 2014, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  278. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

    Article • World Journal of Hepatology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

  279. Trefoil factors in inflammatory bowel disease

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

  280. Chemoembolization of intermediate stage hepatocellular carcinomas: Results from a Nordic tertiary liver cancer center

    Article • Indian Journal of Gastroenterology, December 2013, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  281. Elevated platelet expression of CD36 may contribute to increased risk of thrombo-embolism in active inflammatory bowel disease

    Article • Archives of Physiology and Biochemistry, July 2013, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  282. No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion

    Article • Liver International, June 2013, Wiley

    Clinical Chair Professor Henning Gronbaek

  283. Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience

    Article • Scandinavian Journal of Gastroenterology, June 2013, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  284. Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

    Article • Gastroenterology, June 2013, Elsevier

    Clinical Chair Professor Henning Gronbaek

  285. 591 BACTERIAL DNA MEASUREMENTS IN PATIENTS WITH CIRRHOSIS UNDERGOING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) INSERTION

    Article • Journal of Hepatology, April 2013, Elsevier

    Clinical Chair Professor Henning Gronbaek

  286. 1342 CHANGE IN SOLUBLE CD163, A MARKER OF ACTIVATED MACROPHAGES, IS ASSOCIATED WITH IMPROVEMENT IN LIVER ENZYMES AND METABOLIC PROFILE IN OBESE CHILDREN DURING LIFESTYLE INTERVENTION

    Article • Journal of Hepatology, April 2013, Elsevier

    Clinical Chair Professor Henning Gronbaek

  287. 1301 ENDOTOXIN CAUSES HIGH MORTALITY AND REDUCED HEPATIC SYNTHESIS OF ACUTE PHASE PROTEINS IN RATS WITH EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE

    Article • Journal of Hepatology, April 2013, Elsevier

    Clinical Chair Professor Henning Gronbaek

  288. 1414 THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF).

    Article • Journal of Hepatology, April 2013, Elsevier

    Clinical Chair Professor Henning Gronbaek

  289. Quantitative histological assessment of hepatic ischemia-reperfusion injuries following ischemic pre- and post-conditioning in the rat liver

    Article • Journal of Surgical Research, March 2013, Elsevier

    Clinical Chair Professor Henning Gronbaek

  290. Macrophage biomarkers predict prognosis in patients with liver cirrhosis

    Article • Gut, February 2013, BMJ

    Clinical Chair Professor Henning Gronbaek

  291. Regulation of urea synthesis during the acute-phase response in rats

    Article • AJP Gastrointestinal and Liver Physiology, February 2013, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

  292. Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course

    Article • PLOS One, January 2013, PLOS

    Clinical Chair Professor Henning Gronbaek

  293. Goblet Cell Carcinoids of the Appendix

    Article • The Scientific World JOURNAL, January 2013, Hindawi Publishing Corporation

    Clinical Chair Professor Henning Gronbaek

  294. Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability

    Article • The Scientific World JOURNAL, January 2013, Hindawi Publishing Corporation

    Clinical Chair Professor Henning Gronbaek

  295. Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt

    Article • World Journal of Hepatology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

  296. Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolism

    Article • Clinical Nutrition, December 2012, Elsevier

    Clinical Chair Professor Henning Gronbaek

  297. Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study

    Article • BMC Gastroenterology, December 2012, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  298. Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel® given by either self/partner or a health care professional

    Article • Patient Preference and Adherence, October 2012, Dove Medical Press

    Associate Professor Dan Granberg, PhD Jan Calissendorff, Clinical Chair Professor Henning Gronbaek

  299. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

    Article • Annals of Oncology, September 2012, Oxford University Press (OUP)

    Clinical Chair Professor Henning Gronbaek

  300. Insulin-like Growth Factor-I Concentration and Risk of Prostate Cancer: Results from the European Prospective Investigation into Cancer and Nutrition

    Article • Cancer Epidemiology Biomarkers & Prevention, July 2012, American Association for Cancer Research (AACR)

    Clinical Chair Professor Henning Gronbaek, Francesca Crowe

  301. Ischemic pre- and postconditioning has pronounced effects on gene expression profiles in the rat liver after ischemia/reperfusion

    Article • AJP Gastrointestinal and Liver Physiology, June 2012, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

  302. Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis

    Article • Metabolic Brain Disease, May 2012, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  303. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis

    Article • Alimentary Pharmacology & Therapeutics, May 2012, Wiley

    Clinical Chair Professor Henning Gronbaek

  304. Effects of long-term experimental diabetes on adrenal gland growth and phosphoribosyl pyrophosphate formation in growth hormone-deficient dwarf rats

    Article • International Journal of Experimental Pathology, May 2012, Wiley

    Clinical Chair Professor Henning Gronbaek

  305. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study

    Article • Alimentary Pharmacology & Therapeutics, April 2012, Wiley

    Clinical Chair Professor Henning Gronbaek

  306. 1371 IL-22 PRODUCING T CELLS ARE ASSOCIATED WITH A FAVOURABLE DISEASE COURSE IN ALCOHOLIC HEPATITIS

    Article • Journal of Hepatology, April 2012, Elsevier

    Clinical Chair Professor Henning Gronbaek

  307. 1375 PROGNOSIS OF ALCOHOLIC PURE STEATOSIS AND STEATOHEPATITIS: A NATIONWIDE BIOPSY- AND REGISTRY-BASED STUDY

    Article • Journal of Hepatology, April 2012, Elsevier

    Clinical Chair Professor Henning Gronbaek

  308. 723 SOLUBLE CD163, A MARKER FOR MACROPHAGE ACTIVATION, IS NOT ASSOCIATED TO HCC, PER SE BUT PREDICTS DISEASE PROGRESSION

    Article • Journal of Hepatology, April 2012, Elsevier

    Clinical Chair Professor Henning Gronbaek

  309. Carvedilol or propranolol in portal hypertension? A randomized comparison

    Article • Scandinavian Journal of Gastroenterology, March 2012, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  310. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition

    Article • British Journal of Cancer, February 2012, Nature

    Clinical Chair Professor Henning Gronbaek, Francesca Crowe

  311. Effect of a 10-week Weight Loss Camp on Fatty Liver Disease and Insulin Sensitivity in Obese Danish Children

    Article • Journal of Pediatric Gastroenterology and Nutrition, February 2012, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  312. Effects of long-acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes

    Article • International Journal of Experimental Pathology, January 2012, Wiley

    Clinical Chair Professor Henning Gronbaek

  313. Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumours in a Danish NET Center

    Article • The Scientific World JOURNAL, January 2012, Hindawi Publishing Corporation

    Clinical Chair Professor Henning Gronbaek

  314. Goblet Cell Carcinoid in a Patient with Neurofibromatosis Type 1: A Rare Combination

    Article • Case Reports in Gastrointestinal Medicine, January 2012, Hindawi Publishing Corporation

    Clinical Chair Professor Henning Gronbaek, Tine Gregersen

  315. Prognosis and staging of non-alcoholic fatty liver disease

    Article • BMJ, November 2011, BMJ

    Clinical Chair Professor Henning Gronbaek

  316. Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors

    Article • Scandinavian Journal of Gastroenterology, May 2011, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek, Tine Gregersen

  317. Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS

    Article • Gut, May 2011, BMJ

    Clinical Chair Professor Henning Gronbaek

  318. Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Advanced Neuroendocrine Tumors: Results from a Danish Cohort Treated in Switzerland

    Article • Neuroendocrinology, January 2011, Karger Publishers

    Professor Andreas Kjaer, Clinical Chair Professor Henning Gronbaek, Tine Gregersen

  319. Effects of ischemic pre- and postconditioning on HIF-1α, VEGF and TGF-β expression after warm ischemia and reperfusion in the rat liver

    Article • Comparative Hepatology, January 2011, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  320. IL-6 has no acute effect on the regulation of urea synthesisin vivoin rats

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, December 2010, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  321. Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease

    Article • Scandinavian Journal of Gastroenterology, November 2010, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  322. Expression of genes involved in rat liver angiogenesis after ischaemia and reperfusion: effects of ischaemic pre- and post-conditioning

    Article • HPB, October 2010, Elsevier

    Clinical Chair Professor Henning Gronbaek

  323. Creation of a Fistula Between the Hepatic Duct and the Gastric Lumen by way of Percutaneus Transhepatic Cholangiography: A Case Report

    Article • Journal of Gastrointestinal Cancer, September 2010, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  324. Effect of weight reduction on insulin sensitivity, sex hormone-binding globulin, sex hormones and gonadotrophins in obese children

    Article • European Journal of Endocrinology, September 2010, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  325. A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC)

    Article • Annals of Human Biology, August 2010, Taylor & Francis

    Dr Inger T. Gram, Clinical Chair Professor Henning Gronbaek, Francesca Crowe

  326. Unchanged capacity of urea synthesis during acute phase response in rats

    Article • European Journal of Clinical Investigation, August 2010, Wiley

    Clinical Chair Professor Henning Gronbaek

  327. Insulin sensitivity and body composition in cirrhosis: changes after TIPS

    Article • AJP Gastrointestinal and Liver Physiology, August 2010, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

  328. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours

    Article • Acta Oncologica, June 2010, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  329. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

    Article • The Lancet Oncology, June 2010, Elsevier

    Clinical Chair Professor Henning Gronbaek

  330. Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum

    Article • Clinical Endocrinology, May 2010, Wiley

    Clinical Chair Professor Henning Gronbaek

  331. 169 CARVEDILOL OR PROPRANOLOL IN PORTAL HYPERTENSION? A RANDOMIZED CLINICAL TRIAL

    Article • Journal of Hepatology, April 2010, Elsevier

    Clinical Chair Professor Henning Gronbaek

  332. 514 CIRCULATING SCD163, A SCAVENGER RECEPTOR RELEASED FROM ACTIVATED MACROPHAGES, IS ASSOCIATED WITH PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS

    Article • Journal of Hepatology, April 2010, Elsevier

    Clinical Chair Professor Henning Gronbaek

  333. 586 IMAGING OF NEUROENDOCRINE TUMORS AND LIVER METASTASIS BY F18-DOPA PET SCANNING

    Article • Journal of Hepatology, April 2010, Elsevier

    Clinical Chair Professor Henning Gronbaek

  334. Serum levels of IGF‐I, IGFBP‐3 and colorectal cancer risk: results from the EPIC cohort, plus a meta‐analysis of prospective studies

    Article • International Journal of Cancer, January 2010, Wiley

    Dr Inger T. Gram, Clinical Chair Professor Henning Gronbaek

  335. Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis

    Article • World Journal of Gastroenterology, January 2010, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Jonathan Montomoli, Clinical Chair Professor Henning Gronbaek

  336. Tumor necrosis factor-α acutely up-regulates urea synthesisin vivoin rats – a hepatic component of inflammatory catabolism?

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2010, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  337. Partial Liver Ischemia Is Followed by Metabolic Changes in the Normally Perfused Part of the Liver during Reperfusion

    Article • European Surgical Research, January 2010, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  338. Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections

    Article • World Journal of Hepatology, January 2010, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

  339. Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats

    Article • Growth Hormone & IGF Research, October 2009, Elsevier

    Clinical Chair Professor Henning Gronbaek

  340. The Association between Diet and Serum Concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition

    Article • Cancer Epidemiology Biomarkers & Prevention, May 2009, American Association for Cancer Research (AACR)

    Clinical Chair Professor Henning Gronbaek, Francesca Crowe

  341. 752 EFFECT OF TIPS ON SOLUBLE CD163 IN PATIENTS WITH LIVER CIRRHOSIS

    Article • Journal of Hepatology, April 2009, Elsevier

    Clinical Chair Professor Henning Gronbaek

  342. 159 EFFECTS OF ISCHEMIC PRE- AND POSTCONDITIONING ON HIF-1α, VEGF AND TGF-β EXPRESSION DURING WARM LIVER ISCHEMIA AND REPERFUSION

    Article • Journal of Hepatology, April 2009, Elsevier

    Clinical Chair Professor Henning Gronbaek

  343. 194 INSULIN SENSITIVITY AND BODY COMPOSITION IN CIRRHOSIS: CHANGES AFTER TIPS

    Article • Journal of Hepatology, April 2009, Elsevier

    Clinical Chair Professor Henning Gronbaek

  344. 99 RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER DISEASE: A NATIONWIDE POPULATION- BASED CASE-CONTROL STUDY

    Article • Journal of Hepatology, April 2009, Elsevier

    Clinical Chair Professor Henning Gronbaek

  345. 252 TUMOR NECROSIS FACTOR-ALPHA ACUTELY UP-REGULATES UREA SYNTHESIS IN VIVO IN RATS – A HEPATIC ELEMENT OF INFLAMMATORY CATABOLISM

    Article • Journal of Hepatology, April 2009, Elsevier

    Clinical Chair Professor Henning Gronbaek

  346. The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis

    Article • European Journal of Endocrinology, March 2009, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  347. Cytokine Changes during Warm Ischemia and Reperfusion of the Pig Liver with or without Preconditioning

    Article • European Surgical Research, March 2009, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  348. Risk of Venous Thromboembolism in Patients With Liver Disease: A Nationwide Population-Based Case–Control Study

    Article • The American Journal of Gastroenterology, January 2009, Nature

    Clinical Chair Professor Henning Gronbaek

  349. The influence of preconditioning on metabolic changes in the pig liver before, during, and after warm liver ischemia measured by microdialysis

    Article • Hepatology International, October 2008, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  350. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes

    Article • Expert Review of Gastroenterology & Hepatology, October 2008, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  351. sMAC in plasma and ascites from patients with liver cirrhosis

    Article • Molecular Immunology, October 2008, Elsevier

    Clinical Chair Professor Henning Gronbaek

  352. Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: A Danish population-based case-control study

    Article • BMC Gastroenterology, May 2008, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  353. Soluble CD163 from activated macrophages predicts mortality in acute liver failure

    Article • Journal of Hepatology, November 2007, Elsevier

    Clinical Chair Professor Henning Gronbaek

  354. Metabolic Changes in the Pigliver During Warm Ischemia and Reperfusion Measured by Microdialysis

    Article • Journal of Gastrointestinal Surgery, October 2007, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  355. 3530 POSTER Preliminary results from GEPTOSIS, the international study on medical treatment practice and outcomes in gastroenteropancreatic (GEP) neuroendocrine tumors (NET): variability in the time between initial diagnosis and treatment of GEP NET

    Article • European Journal of Cancer Supplements, September 2007, Elsevier

    Clinical Chair Professor Henning Gronbaek

  356. Portal vein thrombosis; risk factors, clinical presentation and treatment

    Article • BMC Gastroenterology, August 2007, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  357. Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition

    Article • Cancer Epidemiology Biomarkers & Prevention, June 2007, American Association for Cancer Research (AACR)

    Clinical Chair Professor Henning Gronbaek

  358. Impact of Enteral Supplements Enriched with ω–3 Fatty Acids and/or ω–6 Fatty Acids, Arginine and Ribonucleic Acid Compounds on Leptin Levels and Nutritional Status in Active Crohn’s Disease Treated with Prednisolone

    Article • Digestion, April 2007, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  359. Opposite effects on regulation of urea synthesis by early and late uraemia in rats

    Article • Clinical Nutrition, April 2007, Elsevier

    Clinical Chair Professor Henning Gronbaek

  360. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn’s disease: Relations to disease activity and corticosteroid treatment

    Article • Growth Hormone & IGF Research, February 2007, Elsevier

    Clinical Chair Professor Henning Gronbaek

  361. Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention

    Article • BMC Gastroenterology, January 2007, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  362. Effects of five different alcoholic drinks on patients with Crohn's disease

    Article • Scandinavian Journal of Gastroenterology, January 2007, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  363. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition

    Article • International Journal of Cancer, January 2007, Wiley

    Clinical Chair Professor Henning Gronbaek

  364. The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease

    Article • Scandinavian Journal of Gastroenterology, January 2007, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  365. Serum Trefoil Factors in Patients with Inflammatory Bowel Disease

    Article • Digestion, November 2006, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  366. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women

    Article • European Journal of Clinical Nutrition, August 2006, Nature

    Clinical Chair Professor Henning Gronbaek

  367. Quality improvement in wellness reports in patients with Crohn’s disease

    Article • Accreditation and Quality Assurance, June 2006, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  368. Discharge diagnoses of liver diseases in Nuuk Greenland compared to a Danish county hospital

    Article • International Journal of Circumpolar Health, April 2006, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  369. Associations between the IGF system and inflammatory markers in inflammatory bowel disease

    Article • Alimentary Pharmacology & Therapeutics, February 2006, Wiley

    Clinical Chair Professor Henning Gronbaek

  370. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids

    Article • Alimentary Pharmacology & Therapeutics, December 2005, Wiley

    Clinical Chair Professor Henning Gronbaek

  371. Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis

    Article • BMC Gastroenterology, September 2005, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  372. The Insulin-Like Growth Factor System and Markers of Inflammation in Adult Patients with Inflammatory Bowel Disease

    Article • Hormone Research in Paediatrics, August 2005, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  373. Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects

    Article • Growth Hormone & IGF Research, August 2005, Elsevier

    Clinical Chair Professor Henning Gronbaek

  374. Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with ω-3 or ω-6 fatty acids and corticosteroids

    Article • Scandinavian Journal of Gastroenterology, January 2005, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  375. The Involvement of Growth Hormone (GH), Insulin-Like Growth Factors (IGFs) and Vascular Endothelial Growth Factor (VEGF) in Diabetic Kidney Disease

    Article • Current Pharmaceutical Design, October 2004, Bentham Science Publishers

    Clinical Chair Professor Henning Gronbaek

  376. The Influence of Amphotericin B and Neomycin on the Effect of Human Relaxin-2 on Foetal Membranes and Isolated Myometrium

    Article • Basic & Clinical Pharmacology & Toxicology, March 2004, Wiley

    Clinical Chair Professor Henning Gronbaek

  377. Budd‐Chiari and inferior caval vein syndromes due to membranous obstruction of the liver veins: successful treatment with angioplasty and transcaval transjugular intrahepatic porto‐systemic shunt

    Article • Scandinavian Journal of Gastroenterology, January 2004, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  378. Combined liver vein and spleen pulp pressure measurements in patients with portal or splenic vein thrombosis

    Article • Scandinavian Journal of Gastroenterology, January 2004, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  379. Albumin in vaginal fluid is a marker of infection in early pregnancy

    Article • International Journal of Gynecology & Obstetrics, August 2003, Wiley

    Clinical Chair Professor Henning Gronbaek

  380. Editorial

    Article • Synthesis, August 2003, Thieme Publishing Group

    Clinical Chair Professor Henning Gronbaek

  381. Effect of Combination Therapy with a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor on Renal Hypertrophy and Urinary Albumin Excretion in Diabetic Rats

    Article • Experimental Diabesity Research, January 2003, Hindawi Publishing Corporation

    Clinical Chair Professor Henning Gronbaek

  382. Markers of fetal growth and serum levels of insulin-like growth factor (IGF) I, -II and IGF binding protein 3 in adults

    Article • European Journal of Epidemiology, January 2003, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  383. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice

    Article • Journal of Endocrinology, March 2002, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  384. Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment

    Article • The American Journal of Gastroenterology, March 2002, Nature

    Clinical Chair Professor Henning Gronbaek

  385. Effects of octreotide on serum insulin-like growth factor I and insulin-like growth factor binding proteins in patients with cirrhosis

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2002, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

  386. Lessons Learned From Lymphocytes: CC Chemokine Receptor-7 Involved in Lymphogenic Metastasis of Melanoma

    Article • JNCI Journal of the National Cancer Institute, November 2001, Oxford University Press (OUP)

    Clinical Chair Professor Henning Gronbaek

  387. Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity

    Article • European Journal of Immunology, September 2001, Wiley

    Clinical Chair Professor Henning Gronbaek

  388. Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor β receptor expression in experimental diabetes in rats

    Article • Diabetologia, April 2001, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  389. Inhibition of Major Histocompatibility Complex Class II-Dependent Antigen Presentation by Neutralization of Gamma Interferon Leads to Breakdown of Resistance against Measles Virus-Induced Encephalitis

    Article • Journal of Virology, April 2001, ASM Journals

    Clinical Chair Professor Henning Gronbaek

  390. Comparison of the effects of nitrendipine and enalapril on development and progression of diabetic glomerulopathy in streptozotocin-diabetic rats

    Article • Diabetes Research and Clinical Practice, September 2000, Elsevier

    Clinical Chair Professor Henning Gronbaek

  391. Effect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in rats

    Article • American Journal of Kidney Diseases, August 2000, Elsevier

    Clinical Chair Professor Henning Gronbaek

  392. Serum markers for hepatic fibrosis in chronic hepatitis C

    Article • Gastroenterology, April 2000, Elsevier

    Clinical Chair Professor Henning Gronbaek

  393. The Renal Expression of Transforming Growth Factor-  Isoforms and Their Receptors in Acute and Chronic Experimental Diabetes in Rats

    Article • Endocrinology, March 2000, Endocrine Society

    Clinical Chair Professor Henning Gronbaek

  394. Effect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretion

    Article • Journal of Hypertension, July 1999, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

  395. The Calcium Channel Blocker Nitrendipine Attenuates Renal and Glomerular Hypertrophy in Diabetic Rats

    Article • Nephron Experimental Nephrology, May 1999, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

  396. Developmental Changes in Serum Levels of Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit in Rats

    Article • Endocrinology, October 1998, Endocrine Society

    Clinical Chair Professor Henning Gronbaek

  397. Effect of immunosuppression on kidney and serum insulin-like growth factor-I (IGF-I), IGF binding proteins, and renal growth following unilateral nephrectomy in rats

    Article • Metabolism, July 1998, Elsevier

    Clinical Chair Professor Henning Gronbaek

  398. Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats

    Article • Diabetes, June 1998, American Diabetes Association

    Clinical Chair Professor Henning Gronbaek

  399. Growth hormone administration can improve growth in glucocorticoid-injected rats without affecting the lymphocytopenic effect of the glucocorticoid

    Article • Growth Hormone & IGF Research, June 1998, Elsevier

    Clinical Chair Professor Henning Gronbaek

  400. Diabetic kidney disease: the role of growth factors

    Article • Nephrology Dialysis Transplantation, May 1998, Oxford University Press (OUP)

    Clinical Chair Professor Henning Gronbaek

  401. Herpesvirus Saimiri Transforms Human T-Cell Clones to Stable Growth without Inducing Resistance to Apoptosis

    Article • Journal of Virology, April 1998, ASM Journals

    Clinical Chair Professor Henning Gronbaek

  402. Differential expression of renal growth hormone receptor and its binding protein in experimental diabetes mellitus

    Article • Growth Hormone & IGF Research, February 1998, Elsevier

    Clinical Chair Professor Henning Gronbaek

  403. Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes

    Article • Kidney International, January 1998, Elsevier

    Clinical Chair Professor Henning Gronbaek

  404. The Role of Growth Hormone, Insulin-Like Growth Factors, Epidermal Growth Factor and Transforming Growth Factor β in Diabetic Kidney Disease: An Update

    Article • January 1998, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  405. Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats

    Article • AJP Endocrinology and Metabolism, May 1997, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

  406. Changes in Facilitative Glucose Transporter Messenger Ribonucleic Acid Levels in the Diabetic Rat Kidney

    Article • Endocrinology, March 1997, Endocrine Society

    Clinical Chair Professor Henning Gronbaek

  407. Effect of graded renal ablation on kidney and serum insulin-like growth Factor-I (IGF-I) and IGF binding proteins in rats: Relation to compensatory renal growth

    Article • Metabolism, January 1997, Elsevier

    Clinical Chair Professor Henning Gronbaek

  408. The Role of Growth Factors in Diabetic Kidney Disease

    Article • January 1996, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  409. Increased number of myocardial voltage-gated Ca2+ channels and unchanged total  -receptor number in long-term streptozotocin-diabetic rats

    Article • European Journal of Endocrinology, January 1996, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  410. Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats

    Article • AJP Endocrinology and Metabolism, November 1995, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

  411. The role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in experimental diabetic kidney disease

    Article • Metabolism, October 1995, Elsevier

    Clinical Chair Professor Henning Gronbaek

  412. Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention

    Article • Journal of Endocrinology, October 1995, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  413. Effect of Diabetes and Dietary Ubiquinone Supplementation on the Post-translational Modification of Rat Lens βL Crystallin

    Article • Biochemical and Molecular Medicine, August 1995, Elsevier

    Clinical Chair Professor Henning Gronbaek

  414. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes.

    Article • Endocrinology, May 1995, Endocrine Society

    Clinical Chair Professor Henning Gronbaek

  415. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes

    Article • Endocrinology, May 1995, Endocrine Society

    Clinical Chair Professor Henning Gronbaek

  416. Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats

    Article • Journal of Endocrinology, April 1995, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  417. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats

    Article • Diabetologia, February 1995, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  418. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats

    Article • Diabetologia, January 1995, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  419. Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study

    Article • European Journal of Endocrinology, April 1994, Bioscientifica

    Clinical Chair Professor Henning Gronbaek

  420. Roles of Growth Factors in Diabetic Kidney Disease

    Article • January 1994, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  421. Selenium in the central nervous system of rats exposed to 75-Sel-selenomethionine and sodium selenite

    Article • Biological Trace Element Research, November 1992, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

  422. Increased ornithine decarboxylase activity in kidneys undergoing hypertrophy in experimental diabetes

    Article • Molecular and Cellular Endocrinology, July 1992, Elsevier

    Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

  423. Selenium complexes in the anterior pituitary of rats exposed to L-selenomethionine

    Article • Virchows Archiv B Cell Pathology Including Molecular Pathology, December 1990, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek